Full Name
Mr. Timothy Whitten BPharm, MBA
Job Title
President & CEO
Practice/Company Name
Taiho Oncology
Speaker Bio
Tim assumed the role of President & CEO in May 2018, having joined Taiho Pharma U.S.A., Inc. in February 2013 as Chief Commercial Officer. He is uniquely suited to the role, with an MBA and a pharmacy degree. Before joining Taiho, he served as President & CEO of Insmed, Inc., working to help patients with rare and serious lung diseases. Prior to Insmed, he was the President & CEO of Transave, Inc., and held senior management positions at Pharmacyclics and Bristol-Myers Squibb.
Timothy Whitten